Citius Pharmaceuticals, Inc. (CTXR) Operating margin 2017–2022
Citius Pharmaceuticals, Inc. (CTXR) operating margin by fiscal year — reported operating income divided by reported revenue.
-37017.8%FY2022 · since FY2017: -19972.6% → -37017.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -37017.8% | -10871.3 pp |
| FY2021 | -26146.5% | -6468.0 pp |
| FY2020 | -19678.5% | -2347.0 pp |
| FY2019 | -17331.5% | +1054.0 pp |
| FY2018 | -18385.5% | +1587.1 pp |
| FY2017 | -19972.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice